Italian drug-maker Recordati may go to court to block competing takeover bid of leading Polish pharmaceutical company Polfa Kutno by Miami-based Ivax Corp. Recordati's CEO Giovanni Recordati told PARKIET on Monday, his company has asked Securities and Exchanges Commission to investigate competing bid, alleging that Ivax broke Polish securities laws by publishing newspaper ads addressed to Polfa's shareholders.
Information Technology
ComArch reiterates forecasts for 2004
Top Polish maker of billing software, Kraków-based ComArch S.A. expects 20 percent growth in earnings and sales after posting much higher first quarter earnings. Founded in early 1990's, ComArch said it earned 2 million zloty versus 1.55 million zloty last year. The figure for 2003 excludes special gains after ComArch reversed previous provisions on investment in Interia.pl web portal. First-quarter sales were up 47 percent to 37.2 million zloty. During the first quarter the firm signed new contracts with phone companies in Finland, France, Montenegro, Iran and Lithuania totaling PLN 25 million ($6.5 million). Separately, ComArch founder and CEO Janusz Filipiak said this company has no plans to buy back 40 million zloty worth of convertible bonds issued in early 2002 or pay dividends. Instead, ComArch will use some of its cash to build new main office near Kraków. ComArch stock is a component of MIDWIG mid-cap index and TechWIG IT index.
Construction
Projprzem sees record earnings